Curatis Holding AG (SWX:CURN)

Market Cap	70.10M
Revenue	n/a
Net Income	n/a
Shares Out	5.15M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,818
Average Volume	3,423
Open	13.15
Previous Close	13.20
Day's Range	13.15 - 13.80
52-Week Range	9.14 - 15.80
Beta	n/a
RSI	62.21
Earnings Date	n/a

About Curatis Holding AG

Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson’s disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ antibioticum, gentamycin collagen sponge, benign prostatic hy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Roland Rutschmann
• Employees: 20
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: CURN